City of Hope Reveals Vision for World-Class Cancer Care in Orange County

June 25, 2019 | City of Hope

City of Hope has accelerated its plans for a $1 billion comprehensive cancer campus in Orange County, bringing highly specialized cancer care, clinical trials, precision medicine and early detection to the nation’s sixth most populous county.

Continue Reading

Study finds cancer rate rising in millennials

March 6, 2019 | Dory Benford

A new study by the American Cancer Society finds rates of obesity-related cancers — including colorectal, endometrial, pancreatic, kidney, gallbladder and multiple myeloma — rising among young people.

Vanessa Jonsson, Ph.D.: An engineer tackles CAR T cell therapy

February 13, 2019 | City of Hope

Vanessa Jonsson, Ph.D., focuses on chimeric antigen receptor (CAR) T cell therapy. Using such tools as computational analysis and mathematical modeling, she examines the complex interactions between the tumor, the patient’s immune system and the therapy to learn how the tumor evades the immune response.

After multiple myeloma, recording artist plays on

December 18, 2018 | Zen Vuong

Seven City of Hope patients will welcome the New Year atop City of Hope’s 47th Rose Parade float, “Harmony of Hope.” Meet float rider Abraham Laboriel, a world-renowned bassist whose work has been featured in 4,000 recordings and film soundtracks, including “Coco,” “Frozen” and “Incredibles 2.”

New Briskin Center for Clinical Research opens at City of Hope

September 7, 2018 | Michael Easterling

By moving all of the clinical research services and staff to one place, we are enabling many of our patients to complete all of their clinical trial appointments in a single visit at a single location. The Briskin Center includes infusion areas, nursing stations, exam and procedure rooms, onsite pharmacy and lab services, a dedicated registration site and outdoor seating for patients and their families.

What You Should Know About Multiple Myeloma

March 30, 2018 | Kevin Chesley

Multiple myeloma is a blood cancer involving malignant white blood (plasma) cells in the bone marrow. Most often affecting patients 65 and older, it is a debilitating malignancy.

Meet the CAR T Team: Xiuli Wang, Ph.D.

January 4, 2018 | Maxine Nunes

Xiuli Wang, Ph.D., is at the forefront of one of the most exciting breakthroughs in cancer treatment, chimeric antigen receptor (CAR) T cell therapy.

Simon Bray: Beating the Odds

October 2, 2017 | Abe Rosenberg

Simon Bray had been ignoring a chronic backache for months until one day in the gym, he fractured a vertebra. Puzzled by the unusual workout injury, doctors ran a bunch of tests, which revealed multiple myeloma.

CAR T Cell Trial for Multiple Myeloma to Launch in 2017

March 22, 2017 | Travis Marshall

CAR T cell therapy research at City of Hope is an innovative and promising approach that recruits the body’s own immune system in the fight against some of the hardest-to-treat cancers, including multiple myeloma.

‘Dwindling’ ribs, failing kidneys: How one woman climbed back from myeloma

March 21, 2017 | Stephanie Smith

Hypercalcemia (high blood calcium), renal problems, anemia and bone problems, also known by the acronym, C.R.A.B. — reflects the typical symptoms of multiple myeloma. City of Hope follows a multiple myeloma patient, Donna McNutt, who finds ways to cope with her diagnosis.